Showing results (371-380 of 903) with videos related to
Sort By:
Pageof 91
Aktuelle Urologie|March 29, 2019
[Abiraterone plus prednisone in patients with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer (mHSPC)]Kurt MillerAktuelle Urologie|March 23, 2019
Lymphatic micrometastases predict biochemical recurrence in patients undergoing radical prostatectomy and pelvic lymph node dissection for prostate cancerAndreas Maxeiner, Andreas Grevendieck, Therese Pross, et al.Aktuelle Urologie|September 30, 2016
[Strategies for First-Line Treatment of mCRPC]K Miller, J Gschwend, J-M WolffAktuelle Urologie|September 30, 2016
[Significance and Importance of Pelvic Lymphadenectomy in Low-Risk Prostate Cancer Patients]I Janßen, C M Naumann, M Hamann, et al.Aktuelle Urologie|February 7, 2014
[Update Urooncology: News with clinical relevance from major scientific meetings 2013]A Hegele, L Skrobek, A J SchraderAktuelle Urologie|September 20, 2019
Is Medical Therapy for Distal Ureteral Stones Efficient? Tamsulosin versus Deflazacort: A Prospective Randomised TrialSalim Kucukpolat, Ramazan Kocaaslan, Mustafa Kadihasanoglu, et al.Aktuelle Urologie|April 9, 2020
[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]Axel S Merseburger, Christoph Rüssel, Hanjo Belz, et al.Aktuelle Urologie|April 22, 2015
[New biomarkers in serum and urine for detection of prostate cancer]C Stephan, K Jung, K Miller, et al.Aktuelle Urologie|March 6, 2010
[Stromal tumour of uncertain malignant potential of the prostate (STUMP) - a case report]J M Laturnus, M Gebhard, M Sommerauer, et al.Pageof 91